Cadrenal Therapeutics ($CVKD) Insider Trading & Smart Money Activity
Cadrenal Therapeutics, Inc. ($CVKD) has 10 insider trades on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($215.52K), net -$215.52K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 1
- Net insider $ (12 mo)
- -$215.52K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 0
CVKD insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 10 · $215.52K | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All CVKD insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Quang PhamChairman, CEO and Interim CFO | Sell (Open-market sale) 10b5-1 | 9.03K sh | $27.54K | +10.2% | -32.5% | Read | ||||
| Insider | Quang PhamChairman, CEO and Interim CFO | Sell (Open-market sale) 10b5-1 | 2.13K sh | $6.38K | +25.9% | -28.0% | Read | ||||
| Insider | Quang PhamChairman, CEO and Interim CFO | Sell (Open-market sale) 10b5-1 | 2.28K sh | $7.29K | +9.2% | -33.7% | — | ||||
| Insider | Quang PhamChairman, CEO and Interim CFO | Sell (Open-market sale) 10b5-1 | 9.17K sh | $32.54K | -5.0% | -34.0% | — | ||||
| Insider | Quang PhamChairman, CEO and Interim CFO | Sell (Open-market sale) 10b5-1 | 513 sh | $1.62K | -3.9% | -30.3% | Read | ||||
| Insider | Quang PhamChairman, CEO and Interim CFO | Sell (Open-market sale) 10b5-1 | 3.61K sh | $11.49K | +0.7% | -23.4% | Read | ||||
| Insider | Quang PhamChairman, CEO and Interim CFO | Sell (Open-market sale) | 3.67K sh | $13.12K | -4.5% | -29.4% | Read | ||||
| Insider | Quang PhamChairman, CEO and Interim CFO | Sell (Open-market sale) | 3.67K sh | $13.12K | -4.5% | -29.4% | — | ||||
| Insider | Quang PhamChairman, CEO and Interim CFO | Sell (Open-market sale) | 13K sh | $51.20K | -14.1% | -34.6% | Read | ||||
| Insider | Quang PhamChairman, CEO and Interim CFO | Sell (Open-market sale) | 13K sh | $51.20K | -14.1% | -34.6% | Read |
1W / 1M / 6M = how CVKD moved from the trade or filing date.
Insider trading in CVKD: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Quang Pham | Chairman, CEO and Interim CFO | 10 | -$215.52K | Jun 26, 2026 |
Frequently asked questions
Are CVKD insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 10 open-market sales worth $215.52K, a net -$215.52K.
What is the latest insider trade in CVKD?
Quang Pham, Chairman, CEO and Interim CFO filed a sell (open-market sale) of 9.03K sh worth $27.54K on Jun 26, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.